Vancomycin Hydrochloride
Product Images NDC 70594-047

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vancomycin Hydrochloride (NDC 70594-047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vancomycin Carton 10g Xellia

Vancomycin Carton 10g Xellia
This text is a package insert for a drug called Vancomycin, which is prescribed for intravenous use after dilution. The package contains a sterile lyophilized powder that needs to be reconstituted with sterile water for injection. Each 5 mL of the resulting solution contains 500 mg of Vancomycin while each 10 mL contains 1g. The package is not to be used for direct infusion and must be further diluted before use. The usual adult dosage is 2g daily divided doses. The package insert includes important precautions and directions for use. However, it also cautions the user that the text has to be read carefully as certain parts of it are not readable.*
FDA Label Image

Vancomycin Carton 5g Xellia

Vancomycin Carton 5g Xellia
This is a description of Vancomycin Hydrochloride for Injection, which is meant for intravenous use after dilution. The package insert provides precautions and directions for use, including the need for further dilution after reconstitution with 100mL of sterile water before use. There are different concentrations of Vancomycin based on the amount of solution, with 500 mg in each 10 mL and 1 g in each 20 mL. The pharmacy bulk package is for use in a Pharmacy Admixture Service and should be dispensed into infusion fluids using aseptic technique. The bottle should be discarded no later than 4 hours after initial entry. The product is a sterile lyophilized powder and not meant for direct infusion. The usual adult dosage is 2 all, in divided doses. The product is manufactured by Xellia Pharmaceuticals USA, LLC in Denmark.*
FDA Label Image

Vancomycin Structure Xellia

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.